Precise Biometrics AB (publ) (STO:PREC)

Market Cap	262.63M
Revenue (ttm)	85.18M
Net Income (ttm)	-12.66M
Shares Out	77.38M
EPS (ttm)	-0.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	160,002
Average Volume	142,798
Open	3.380
Previous Close	3.394
Day's Range	3.254 - 3.452
52-Week Range	2.730 - 7.290
Beta	0.71
RSI	56.70
Earnings Date	Aug 15, 2025

About Revance Therapeutics

Precise Biometrics AB (publ) operates in the field of cybersecurity and biometric solutions in Sweden, Taiwan, China, the United States, and internationally. The company operates in two segments, Digital Identity and Biometric Technologies. It offers YOUNiQ Access, a physical access management system based on biometrics, such as facial recognition; YOUNiQ Visit system for secure and efficient visitor management in companies; Precise BioMatch Automotive for identity authentication in cars and other automotive; and Precise BioMatch Smart Card for...

• Industry: Security & Protection Services
• Sector: Industrials
• Founded: 1997
• Employees: 35
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: PREC

Financial Performance

In 2024, Precise Biometrics AB's revenue was 86.85 million, an increase of 15.70% compared to the previous year's 75.07 million. Losses were -8.43 million, -68.06% less than in 2023.